Jamie Rice
About Jamie Rice
Jamie Rice is a Director at Roivant Sciences in Boston, Massachusetts, where he has worked since 2021. He has extensive experience in drug development, particularly in immuno-oncology and autoimmune diseases, with a strong academic background in molecular and cell biology.
Work at Roivant Sciences
Jamie Rice has served as Director at Roivant Sciences since 2021. In this role, based in Boston, Massachusetts, he leads initiatives related to drug development, particularly in the fields of immuno-oncology and auto-inflammatory/autoimmune diseases. His experience at Roivant Sciences includes a previous position as Principal Investigator for a brief period in 2021.
Previous Experience in Biotechnology
Prior to his current role, Jamie Rice worked at Silicon Therapeutics as a Senior Investigator from 2016 to 2019 and later as Principal Investigator from 2019 to 2021. His tenure at Silicon Therapeutics involved significant contributions to drug development projects targeting immuno-oncology and auto-inflammatory/autoimmune disease indications.
Educational Background
Jamie Rice completed his Bachelor of Science in Physiology and Neurobiology at the University of Connecticut from 1998 to 2002. He furthered his education at the same institution, earning a PhD in Molecular and Cell Biology from 2009 to 2014. Additionally, he participated in a Healthcare Innovation and Commercialization Course at Harvard Medical School in 2016.
Research and Academic Roles
Jamie Rice has held various research and academic positions. He was a Postdoctoral Fellow at the University of Connecticut in 2014 and at Harvard Medical School from 2015 to 2016. He also worked as a Research Fellow at Boston Children's Hospital during the same period. His early career included a role as a Research Scientist/Consultant at Ciencia Inc. from 2007 to 2015.
Expertise in Drug Development
Jamie Rice possesses expertise in leading drug development projects, specifically in immuno-oncology and auto-inflammatory/autoimmune diseases. His strong background in molecular and cell biology, along with physiology and neurobiology, supports his contributions to the field of drug development.